Abstract
• Early referral, early diagnosis and early introduction of disease modifying antirheumatic drug (DMARD) therapy can improve the course of rheumatoid arthritis. • DMARD therapy, with the aim of reducing joint inflammation, can prevent joint damage and limit functional disability. • Regular monitoring of disease activity and for drug toxicity is important. • Screening and management of vascular risk factors and osteoporosis are necessary in patients with rheumatoid arthritis. • Patient education and support are crucial in management.
Original language | English |
---|---|
Pages (from-to) | 43-52 |
Number of pages | 10 |
Journal | Medicine Today |
Volume | 8 |
Issue number | 1 |
Publication status | Published - Jan 2007 |
Externally published | Yes |